The two modifications were (1) decreasing the tumor size cutoff from 5 cm to 3 cm and (2) decreasing the CEA level cutoff from 200 ng/mL to 30 ng/mL [134,145]. This evidence concerns the gene CEACAM5 and neoplasm.